Input costs declined 13.2% for the quarter
PHOTO
Sun Pharmaceutical Industries Ltd, India's largest drugmaker by revenue, on Friday reported a 29.6% rise in fourth-quarter profit, as it benefited from lower expenses.
The company's consolidated profit before exceptional items and tax rose to 24.11 billion rupees ($291.7 million) for the quarter ended March 31, it said in an exchange filing.
Input costs declined 13.2% for the quarter.
($1 = 82.6420 Indian rupees) (Reporting by Rama Venkat in Bengaluru; Editing by Varun H K)
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
© ZAWYA 2024
